Menu
  • Home
  • About Us
    • About 340B Report
    • Who We Are
    • Testimonials
    • Work With 340B Report
    • Contact
  • Subscribe Now
  • Document Center
  • Expert Directory
  • Events Calendar
  • Industry Insights
  • Sponsor/Advertise
  • Sign in
340B Report

340B Report

Category: Breaking

BREAKING: 22 U.S. Senate Democrats Want Answers from PhRMA About its Members’ 340B Actions

In Breaking, Federal, Legislative, Pharma Industry, RegulatorySeptember 15, 2020 Tom Mirga
SPONSORED BY


…

Read More »

BREAKING: More than Half of the U.S. House Asks Azar to Address Drug Makers’ 340B Actions Immediately

In Breaking, Federal, Legislative, Pharma Industry, RegulatorySeptember 14, 2020 Tom Mirga
SPONSORED BY


…

Read More »

BREAKING: House Democratic Committee Chairs Say Drug Companies’ Actions Could Put 340B on “Treacherous Path”

In Breaking, Federal, Legislative, Pharma Industry, RegulatorySeptember 3, 2020 Tom Mirga
SPONSORED BY


…

Read More »

BREAKING: HRSA is Investigating Whether Manufacturer Policies to Restrict 340B Pricing at Contract Pharmacies Violates Statute

In Breaking, Federal, Pharma Industry, RegulatorySeptember 2, 2020 Tom Mirga
SPONSORED BY


…

Read More »

BREAKING: Eli Lilly Comment on Today's Actions

In Breaking, Federal, Pharma Industry, RegulatorySeptember 1, 2020 Tom Mirga

After publication, 340B Report received the following comment from Eli Lilly and Co. on its actions that we reported on today:

Report after report shows 340B is not working for patients and needs reform. We support recent executive

…
Read More »

BREAKING: Kalderos Wants to Give Drug Manufacturers a Way to Pay 340B Rebates in Lieu of Discounts

In Breaking, Federal, Pharma Industry, RegulatoryAugust 25, 2020 Tom Mirga
SPONSORED BY


…

Read More »

BREAKING: Novartis the Latest to Seek 340B Contract Pharmacy Claims Data

In Breaking, Federal, Pharma Industry, RegulatoryAugust 18, 2020 Tom Mirga
SPONSORED BY


A

…
Read More »

BREAKING: AstraZeneca Raises the Ante in Drug Industry Push Against 340B Contract Pharmacy

In Breaking, Federal, Pharma Industry, RegulatoryAugust 17, 2020 Tom Mirga
SPONSORED BY


…

Read More »

BREAKING: Omnicell Buys PSG’s 340B Line of Business, the Latest in a Trend of 340B TPA Acquisitions

In Breaking, Other IndustryAugust 12, 2020 Tom Mirga

Omnicell’s purchase today of PSG’s 340B
…
Read More »

BREAKING: Health Centers Challenge Administration Suggestions They Put 340B Profits Over Patients

In Breaking, Federal, Regulatory, Trade AssociationJuly 25, 2020 Tom Mirga
SPONSORED BY


…

Read More »

Posts navigation

1 2 3 4 5

Site Sidebar

Categories

  • Breaking
  • Federal
  • Judicial
  • Legislative
  • Non-Governmental
  • Other Industry
  • Pharma Industry
  • Regulatory
  • Research/Reports
  • State
  • Trade Association
  • Uncategorized

Recent Posts

  • Our First Issue Behind Our Paywall
  • Gilead Adjusts Planned Change in its Patient Assistance After HIV Community Pushes Back
  • HHS Asks Court to Toss Out Hospitals’ 340B Contract Pharmacy Lawsuit
  • View From Capitol Hill: An Inside Look at the Latest Developments Shaping the 340B Program
  • Senate Finance Report Might Shed Light on Insulin Manufacturers’ 340B Contract Pharmacy Actions

Site Footer

Terms of Use Privacy Policy